PreprintArticleVersion 1This version is not peer-reviewed
Exploring the Impact of IL-33 Gene Polymorphism (rs1929992) on Susceptibility to Chronic Urticaria and its Association with Serum Interleukin-33 levels
Version 1
: Received: 25 September 2024 / Approved: 25 September 2024 / Online: 26 September 2024 (17:07:22 CEST)
How to cite:
Dobrican-Băruța, C.-T.; Deleanu, D. M.; Iancu, M.; Muntean, I. A.; Nedelea, I.; Bălan, R.-G.; Procopciuc, L. M.; Filip, G. A. Exploring the Impact of IL-33 Gene Polymorphism (rs1929992) on Susceptibility to Chronic Urticaria and its Association with Serum Interleukin-33 levels. Preprints2024, 2024092089. https://doi.org/10.20944/preprints202409.2089.v1
Dobrican-Băruța, C.-T.; Deleanu, D. M.; Iancu, M.; Muntean, I. A.; Nedelea, I.; Bălan, R.-G.; Procopciuc, L. M.; Filip, G. A. Exploring the Impact of IL-33 Gene Polymorphism (rs1929992) on Susceptibility to Chronic Urticaria and its Association with Serum Interleukin-33 levels. Preprints 2024, 2024092089. https://doi.org/10.20944/preprints202409.2089.v1
Dobrican-Băruța, C.-T.; Deleanu, D. M.; Iancu, M.; Muntean, I. A.; Nedelea, I.; Bălan, R.-G.; Procopciuc, L. M.; Filip, G. A. Exploring the Impact of IL-33 Gene Polymorphism (rs1929992) on Susceptibility to Chronic Urticaria and its Association with Serum Interleukin-33 levels. Preprints2024, 2024092089. https://doi.org/10.20944/preprints202409.2089.v1
APA Style
Dobrican-Băruța, C. T., Deleanu, D. M., Iancu, M., Muntean, I. A., Nedelea, I., Bălan, R. G., Procopciuc, L. M., & Filip, G. A. (2024). Exploring the Impact of IL-33 Gene Polymorphism (rs1929992) on Susceptibility to Chronic Urticaria and its Association with Serum Interleukin-33 levels. Preprints. https://doi.org/10.20944/preprints202409.2089.v1
Chicago/Turabian Style
Dobrican-Băruța, C., Lucia Maria Procopciuc and Gabriela Adriana Filip. 2024 "Exploring the Impact of IL-33 Gene Polymorphism (rs1929992) on Susceptibility to Chronic Urticaria and its Association with Serum Interleukin-33 levels" Preprints. https://doi.org/10.20944/preprints202409.2089.v1
Abstract
Chronic urticaria (CU) is a debilitating skin condition affecting up to 20% of the global popula-tion, characterized by erythematous, maculo-papular lesions and significant quality of life im-pairment. This study focused on the role of interleukin 33 (IL-33) and its polymorphisms, partic-ularly SNP rs1929992, in chronic spontaneous urticaria (CSU). Using demographic, clinical, and laboratory data from CU patients and controls, we aestimated allele and genotype frequencies, Hardy-Weinberg equilibrium condition, and serum IL-33 levels, using unconditional binomial logistic regression for association analysis. Results revealed that CU patients had significantly higher frequencies of the minor allele of IL33 rs1929992 compared to controls (31.25% vs. 17.35%, p = 0.024), and carriers of the AG genotype exhibited increased odds of CU (adjusted OR = 2.208, p ≤ 0.001). Additionally, serum IL-33 levels were markedly elevated in CU patients, par-ticularly those with the GA genotype. The findings suggest that the IL-33 SNP rs1929992 is asso-ciated with an increased susceptibility to CSU, emphasizing its potential as a diagnostic and therapeutic biomarker. This study underscores the genetic and immunological underpinnings of CSU, paving the way for personalized treatment approaches.
Keywords
chronic urticaria; genetic polymorphisms; IL-33; SNP rs1929992; cytokine; autoimmune; susceptibility
Subject
Medicine and Pharmacology, Immunology and Allergy
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.